User profiles for Florent Wallet
 | Florent WalletMedecin, hospices civils de Lyon, université Lyon 1 Verified email at chu-lyon.fr Cited by 4573 |
[HTML][HTML] Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3 …
…, V Tolsma, JM Turmel, F Valour, F Wallet… - The Lancet infectious …, 2022 - thelancet.com
Background The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial.
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …
Prevalence of obesity among adult inpatients with COVID-19 in France
382: 727–33. 2 Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics
of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. …
of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. …
Skin antisepsis with chlorhexidine–alcohol versus povidone iodine–alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection …
Background Intravascular-catheter-related infections are frequent life-threatening events in
health care, but incidence can be decreased by improvements in the quality of care. …
health care, but incidence can be decreased by improvements in the quality of care. …
[HTML][HTML] Obesity is associated with severe forms of COVID‐19
TO THE EDITOR: We read with great interest the Brief Cutting Edge Report from Simonnet
et al.(1), which reported a high prevalence of obesity in severe acute respiratory syndrome …
et al.(1), which reported a high prevalence of obesity in severe acute respiratory syndrome …
Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical …
Importance High-flow nasal oxygen therapy is increasingly used for acute hypoxemic
respiratory failure (AHRF). Objective To determine whether high-flow oxygen therapy decreases …
respiratory failure (AHRF). Objective To determine whether high-flow oxygen therapy decreases …
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study
Background Patients with severe COVID-19 have emerged as a population at high risk of
invasive fungal infections (IFIs). However, to our knowledge, the prevalence of IFIs has not yet …
invasive fungal infections (IFIs). However, to our knowledge, the prevalence of IFIs has not yet …
Complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: risk factors for ICU admission …
S Malfroy, F Wallet, D Maucort-Boulch, L Chardonnal… - Surgical oncology, 2016 - Elsevier
Background and objectives For patients suffering from peritoneal carcinomatosis, cytoreductive
surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is the only curative …
surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is the only curative …
Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute …
Background Non-invasive ventilation has never been compared with high-flow oxygen to
determine whether it reduces the risk of severe hypoxaemia during intubation. We aimed to …
determine whether it reduces the risk of severe hypoxaemia during intubation. We aimed to …
Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 cases
…, A Piton, E Richter, K Toufik, MC Vogler, F Wallet… - Intensive care …, 2015 - Springer
Background In the intensive care unit (ICU), the outcomes of patients with acute mesenteric
ischemia (AMI) are poorly documented. This study aimed to determine the risk factors for …
ischemia (AMI) are poorly documented. This study aimed to determine the risk factors for …
Commercial anti‐CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center
Two autologous anti‐CD19 chimeric antigen receptors (CAR) T cells (axicabtagene ciloleucel
[axi‐cel] and tisagenlecleucel [tisa‐cel]) are commercially approved in Europe for relapsed…
[axi‐cel] and tisagenlecleucel [tisa‐cel]) are commercially approved in Europe for relapsed…